Health · Pharma & Biotech · 1 day ago
Boston Scientific unveils China-made GX1 pain treatment device
Boston Scientific and Chinese medical company Acotec Medical unveiled a China-made version of the GX1 device in Shanghai during the China International Import Expo.
The device uses radiofrequency energy to target nerves or tissues linked to pain, and offers heat and pulsed treatment modes.
The companies are working together under China’s medical device registration-holder system, with production planned in China and a focus on the domestic market.
The device is intended as an option for some people whose pain is not well controlled by medicines or who cannot tolerate their side effects.
Neuropathic pain affects an estimated 6% to 7.7% of the general population, and China has nearly 90 million patients, according to the supplied information.
The company says the upgraded device includes real-time monitoring of electrode contact and changes designed to make it easier to use.
It has not yet been launched in mainland China, and no launch date is given.
Boston Scientific unveiled a China-made version of its GX1 radiofrequency ablation treatment system at the China International Import Expo in Shanghai.
The device was developed through a partnership with Chinese company Acotec Medical under China’s medical device marketing authorization holder system.
It is planned for production in China and is intended mainly for the domestic market.
The system offers thermal coagulation and pulsed radiofrequency modes, along with upgrades including real-time electrode contact monitoring.
The product has not yet launched in mainland China.
- Who
- Boston Scientific and Chinese medical device company Acotec Medical.
- What
- They unveiled a China-made version of the GX1 radiofrequency ablation treatment system.
- When
- November 6, 2026, during the ninth China International Import Expo.
- Where
- Shanghai, China.
- Why
- The partnership aims to bring the technology into production in China, serve domestic demand and support pain treatment.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Partnership
- Boston Scientific and Acotec Medical
- Planned production
- China
- Intended market
- Mainly the domestic Chinese market
- Treatment modes
- Thermal coagulation and pulsed radiofrequency
- Device weight
- 24 pounds
- Regulatory status
- Not yet launched in mainland China
What people are saying
希望通过与先瑞达医疗的携手合作，加速GX1治疗仪在中国的应用进程，推动创新治疗技术更快惠及国内患者，共同支持中国疼痛治疗的规范化发展。